Vu, T., Ma, P., Chen, J. S., de Hoon, J., Van Hecken, A., Yan, L., . . . Vargas, G. (2017). Pharmacokinetic-Pharmacodynamic Relationship of Erenumab (AMG 334) and Capsaicin-Induced Dermal Blood Flow in Healthy and Migraine Subjects. Pharmaceutical research, 34(9), 1784-1795. https://doi.org/10.1007/s11095-017-2183-6
Chicago Style (17th ed.) CitationVu, Thuy, Peiming Ma, Jiyun Sunny Chen, Jan de Hoon, Anne Van Hecken, Lucy Yan, Liviawati Sutjandra Wu, Lisa Hamilton, and Gabriel Vargas. "Pharmacokinetic-Pharmacodynamic Relationship of Erenumab (AMG 334) and Capsaicin-Induced Dermal Blood Flow in Healthy and Migraine Subjects." Pharmaceutical Research 34, no. 9 (2017): 1784-1795. https://doi.org/10.1007/s11095-017-2183-6.
MLA (9th ed.) CitationVu, Thuy, et al. "Pharmacokinetic-Pharmacodynamic Relationship of Erenumab (AMG 334) and Capsaicin-Induced Dermal Blood Flow in Healthy and Migraine Subjects." Pharmaceutical Research, vol. 34, no. 9, 2017, pp. 1784-1795, https://doi.org/10.1007/s11095-017-2183-6.